The incomplete specification of CAPS subtypes in the literature (FCAS vs. NOMID) also limits interpretation, but available evidence suggests that TNF blockade is insufficient to control inflammasome-driven inflammation dominated by IL-1 signaling. The gene discussed is TNF; the disease is cryopyrin-associated periodic syndrome.